Form 4: Merit Medical Systems Director Sells Shares Under Pre-Arranged Trading Plan

Merit Medical Systems Director Michael R. McDonnell sold a total of 3,500 shares of common stock in two transactions in late May and early June 2025, pursuant to a Rule 10b5-1 trading plan.

Summary

• Michael R. McDonnell, a Director of Merit Medical Systems Inc. (MMSI), reported two sales of common stock.
• On May 30, 2025, Mr. McDonnell sold 1,750 shares of common stock at a price of $94.30 per share.
• On June 2, 2025, an additional 1,750 shares of common stock were sold at a price of $94.51 per share.
• These sales were executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. McDonnell on February 28, 2025.
• Following the transaction on May 30, 2025, Mr. McDonnell beneficially owned 8,145 shares of common stock.
• After the transaction on June 2, 2025, Mr. McDonnell's beneficial ownership decreased to 6,395 shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the fact that these sales were conducted under a pre-arranged Rule 10b5-1 trading plan mitigates any concerns about the timing or motivation of the sales, making it a routine disclosure.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating that the transactions were scheduled in advance and not based on immediate, non-public information.

Negatives

• Insider selling, even under a 10b5-1 plan, reduces the direct equity stake of a company director, which can sometimes be perceived as a slight negative signal by investors.

Future Outlook

NA

Industry Context

This Form 4 filing reports a routine insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders may note the reduction in a director's direct equity holding, but the pre-arranged nature of the sales (10b5-1 plan) suggests these are for personal financial planning rather than a reflection of company-specific concerns.

Key Dates

Keywords

Merit Medical Systems, MMSI, Form 4, Insider Trading, Stock Sale, Director, Michael R. McDonnell, 10b5-1 Plan, Beneficial Ownership